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Abstract
Background: The presence of indistinguishable strains of Clostridium difficile in humans, food animals and food, as
well as the apparent emergence of the food-animal-associated ribotype 078/toxinotype V as a cause of
community-associated C. difficile infection have created concerns about the potential for foodborne infection. While
studies have reported C. difficile in calves, studies of cattle closer to the age of harvest are required. Four
commercial feedlots in Alberta (Canada) were enrolled for this study. Fecal samples were collected at the time of
arrival and after acclimation (< 62, 62-71 or > 71 days on feed). Selective culture for Clostridium difficile was
performed, and isolates were characterized by ribotyping and pulsed-field gel electrophoresis. A logistic regression
model was built to investigate the effect of exposure to antimicrobial drugs on the presence of C. difficile.
Results: Clostridium difficile was isolated from 18 of 539 animals at the time of feedlot arrival (CI = 2.3-6.1) and
from 18 of 335 cattle at mid-feeding period (CI = 2.9-13.1). Overall, there was no significant difference in the
prevalence of C. difficile shedding on arrival versus mid-feeding period (P = 0.47). No association between shedding
of the bacterium and antimicrobial administration was found (P = 0.33). All the isolates recovered were ribotype
078, a toxinotype V strain with genes encoding toxins A, B and CDT. In addition, all strains were classified as NAP7
by pulsed field gel electrophoresis (PFGE) and had the characteristic 39 base pairs deletion and upstream
truncating mutation on the tcdC gene.
Conclusions: It is apparent that C. difficile is carried in the intestinal tracts of a small percentage of feedlot cattle
arriving and later in the feeding period and that ribotype 078/NAP7 is the dominant strain in these animals. Herd
management practices associated with C. difficile shedding were not identified, however further studies of the
potential role of antimicrobials on C. difficile acquisition and shedding are required.
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Background
Clostridium difficile is a Gram-positive, spore-forming
bacterium responsible for C. difficile infection (CDI) in
humans [1], a serious and increasingly problematic disease.
A remarkable change in the epidemiology of CDI has been
encountered over the past 10 years, with increasing inci-
dence, mortality and relapse rates in humans [2,3]. Addi-
tionally, while classically a hospital-associated pathogen
predominantly affecting elderly individuals, there are
increasing reports of community-associated CDI, includ-
ing disease in younger individuals and people with few or
no traditional risk factors [1,4,5].
The source of infection for community-associated cases
of CDI remains uncertain, however foodborne infection
has been suggested [4]. Indeed, several studies have
recovered spores of C. difficile from food products
including retail meat [6-9], yet the source of contamina-
tion for food products has not been identified. Contami-
nation of carcasses during slaughter and processing is
most likely [10,11], but the presence of dormant spores
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of the bacterium in the muscle tissues of food animals
should also be considered [12].
While currently unproven, concerns about zoonotic
and foodborne transmission of CDI are reasonable con-
sidering reports of isolation of C. difficile from animals.
Concern has been heightened by the apparent increase
in CDI in humans caused by the C. difficile ribotype 078
[4,13,14], a strain that has been associated with commu-
nity-associated infection [15,16] since this is the domi-
nant C. difficile strain among food animals [15,17-19]
and has also been recovered from meat products [8,9].
High prevalences of C. difficile shedding have been
reported in food animals, yet most studies have involved
young animals well before the time of slaughter. Studies
of animals performed nearer to the time of slaughter are
likely more relevant for assessment of the potential for
foodborne exposure, yet limited epidemiological investi-
gations have been performed in feedlot cattle [11,20].
The objectives of this study were to evaluate the shed-
ding of C. difficile by adult feedlot cattle upon arrival and
after acclimation to the feedlot diet and environment, and
to characterize the recovered isolates. In addition, the
potential association between the use of antimicrobial
drugs and shedding of the bacterium was also investigated.
Results
A total of 539 cattle were sampled from 4 feedlots, ranging
from 121 to 179 cattle per feedlot (mean 135). Adjusting
for lack of independence in pens, C. difficile was isolated
overall from 3.7% of 539 (CI = 2.3-6.1) animals at the time
of feedlot arrival in 34 unique pens and from 6.2% of 335
(CI = 2.9-13.1) cattle at mid-feeding period in 22 unique
pens. No individuals were positive at both sampling times.
Results of the regression analysis using generalized esti-
mating equation (GEE), accounting for the date of sam-
pling during the feeding period (< 62 days on feed (DOF),
62-71 DOF, or > 71DOF) and for the effects of repeated
sampling are presented in Table 1. There was no statisti-
cally detectable difference in the likelihood of recovery of
C. difficile based on DOF (P = 0.47).
Sixty-four individuals were treated with parenteral anti-
microbials during the study period including beta-lactams
(2), macrolides (32), phenicols (1), quinolones (1), sulfona-
mides (1) and tetracyclines (27). The sum of the Animal
Defined Daily Dose (ADD), which quantifies the total
amount of antimicrobials administered for each period
and for the total risk period were 11, 96, 3, 3, 3 and 54 for
each of the drug classes, respectively. Tetracycline was the
only in-feed antimicrobial used and was given to all indivi-
duals, with a summed ADD of 1278.4. As shown in Table
1, there was no significant association between the use of
tetracycline and the prevalence of C. difficile in these ani-
mals (P = 0.33). Results for models regarding the remain-
ing antimicrobials are not shown, as the univariable
logistic regression models did not converge.
One isolate could not be recovered after storage and
therefore, molecular analysis was performed on the remain-
ing 35 isolates. All the isolates recovered were classified as
ribotype 078 and were positive for the toxin producing
genes tcdA, tcdB and cdtA. All isolates were indistinguish-
able on PFGE and classified as North American pulsotype
7 (NAP 7) (Figure 1). As expected, sequencing of the tcdC
gene identified a 39 bp deletion and C184T upstream trun-
cating mutation, consistent with the tcdC-A genotype
according to Curry et al. [21].
Discussion
The prevalence of feedlot cattle shedding C. difficile was
low at both sampling times. There is a limited number of
studies concerning the epidemiology of C. difficile in the
bovine species and the data available in the literature are
Table 1 Univariable associations of use of antimicrobials
with prevalence of C.difficile and prevalence at different
periods*
Class of antimicrobial Odds ratio 95% CI P-value
IN FEED 0.33
Tetracycline 0.77 0.55-1.08
DAYS ON FEED 0.47
< 62 4.25 0.73-24.63
62-71 1.07 0.21-5.38
> 71 Referent Referent
* controlling for lack of independence sampling
Figure 1 Pulsed-field gel electrophoresis of Clostridium difficile
isolates recovered from beef cattle entering feedlots. Pulsed-
field gel electrophoresis of Clostridium difficile isolates recovered
from beef cattle entering feedlots. Figure 1 legend: Lanes 1, 8 and
15 contain a PFGE ladder (50-1000 kb). Lane 3 has an unrelated
sample and lanes 6 and 14 are empty. The remaining lanes show
NAP7 C. difficile.
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largely restricted to calves [17,18,22-24]. The low shedding
prevalence of C. difficile in cattle arriving at feedlots
reported here is in agreement with the prevalence reported
by Indra et al. [2] in cows (4.5%) and slightly higher than
the one reported by Rodriguez-Palacios et al. [20] in fee-
dlot cattle at harvest age (1.8%). However, our results indi-
cate a lower shedding prevalence than the one found by
Rodriguez-Palacios et al. [11] whom isolated the bacterium
from 12.9% of animals arriving to feedlot. The reasons for
this difference cannot be explained, however stressing
from shipping and different management conditions prior
to arrival such as hygiene, population, stocking density,
animal mixing and antimicrobial administration should be
considered, along with potential geographic variation and
differences in methodology.
A high prevalence of C. difficile shedding has been
reported in young calves. The bacterium was recovered
from 14.9% of healthy calves in one study [24] and from
12.7% in another [18], but it can be as high as 51% in veal
calves [17]. In addition, C. difficile has been detected by
PCR in feces of 33.8% of calves submitted for post-mortem
examination [23]. The lower prevalence in this and the
above-cited studies of older animals is perhaps not surpris-
ing given increasing evidence of a strong effect of age on
C. difficile shedding prevalence, something that has been
noted in swine [25-27] and horses, [28], as well as humans
[29]. Costa et al. [17] also observed a significant decrease
in shedding prevalence (from 32% to 2%) as veal calves
became older, which is in agreement with Hoffer et al.
[22], who isolated C. difficile from only one out of 204 veal
calves sampled at slaughter. The reasons for a higher shed-
ding prevalence in young individuals are uncertain but
competition from a more adapted intestinal microflora in
older animals may make colonization more difficult. In
addition, stress from birth adaptation, a naïve immune
response, the type of feeding and the different manage-
ment systems could also explain the increased prevalence
in younger animals.
The potential for antimicrobial drugs to disrupt the nor-
mal intestinal microflora leading to C. difficile overgrowth
has been shown in other species, including humans [30]
and horses [28]. Therefore, in order to further investigate
the effect of C. difficile shedding by animals from feedlot,
antimicrobial exposure of cattle was investigated. Antimi-
crobial exposure, particularly tetracyclines, was common
however no influence on C. difficile shedding was identi-
fied. The lack of an identifiable association between the
use of antimicrobials and shedding of C. difficile reported
here agrees with the findings of Rodriguez-Palacios et al.
[11].
Ribotype 078, the only strain found here, can cause
CDI in humans [4,14] and has been increasingly asso-
ciated with community-associated CDI [13,15]. A study
of human and animal ribotype 078 isolates using highly
discriminatory multilocus variable number tandem repeat
analyses indicated they were closely related, suggesting
that the bacterium may be transmitted between humans
and animals [31]. The predominance of this strain was
not particularly surprising since it is typically associated
with food animals, has been found in various studies of
pigs and cattle and it is the most commonly reported
strain in pigs in Canada [2,17-19,22,31,32]. In addition,
the strain has been prevalent (between 73% and 86%)
among isolates recovered from some retail beef samples
[8,9]. Another interesting aspect was the finding that no
cattle were positive at both sampling times. This suggests
that persistent carriers are not common, and that C. diffi-
cile may be transiently shed and circulated throughout
animal populations. Inconsistent or transient shedding
has also been reported in dogs [33] and horses [34].
Further studies involving more frequent sampling would
help elucidate the on-farm cycling of C. difficile.
The predominance of clones classified as ribotype 078/
NAP7 recovered from beef cattle reported here (100%)
reinforces the results of other studies in the bovine species
[17-19,22]. However, other researchers found that only 2
out of 24 [11] and 1 out of 17 [20] isolates recovered from
cattle were ribotype 078. In addition, it was interesting
that other strains, including 027/NAP III, found in retail
beef [6,8,9] were not isolated in the present study.
The prevalence of shedding of C. difficile ribotype 078
by feedlot cattle reported here is an important information
for a better understanding of C. difficile epidemiology in
adult beef cattle. The low prevalence upon feedlot arrival
and later in the feeding period must be considered when
interpreting food contamination and foodborne risks. The
lack of an effect of antimicrobials exposure was interesting
and while a study such as this cannot completely discount
a role of antimicrobials in the epidemiology of C. difficile
in cattle, it is clearly not a major determinant, at least on
these farms.
Conclusions
We conclude that the prevalence of C. difficile in adult
cattle was low at arrival and at mid-feeding period from
feedlots. No association was found between exposure to
antimicrobial drugs or between days on feed and the
prevalence of C. difficile in this collection of samples.
Ribotype 078/NAP7 was the only strain present among
all isolates recovered. It is apparent that C difficile is
carried in the intestinal tracts of a small percentage of
beef cattle going to slaughter, but its public health sig-
nificance requires further study.
Methods
Animal selection
Cattle enrolled in this study were managed at four wes-
tern Canadian feedlots in south central Alberta, under
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production conditions that are typical of those used at
large commercial cattle feedlots throughout western
Canada and the United States. Feedlots had one-time
capacities between 15,000 and 20,000 animals, with pens
capable of housing 50 to 350 animals. Animals are
housed in open-air, dirt-floor pens arranged side by side
with central feed alleys and 20% porosity wood-fence
windbreaks. All feedlots have modern cattle handling
facilities. Each animal handling facility has a hydraulic
chute equipped with an individual animal scale, a chute-
side computer with software for individual animal data
collection and management (iFHMS, Feedlot Health
Management Services Ltd., Okotoks, Alberta) and
separation alleys to facilitate the return of animals to
designated pens. All animal handling and sampling pro-
cedures were approved prior to the initiation of the
study by the University of Guelph Animal Care Com-
mittee, the Animal Care Committee of Feedlot Health
Management Services (FHMS) and the Institutional Ani-
mal Care and Use Committee of Colorado State
University.
Candidate animals utilized in the study were procured
through the auction market system across western
Canada. Various cattle types were fed at these feedlots
including cattle of various entry weights, age classes
(calves and yearlings), frame sizes, sources (e.g., ranch-
direct cattle and back-grounded cattle), and genders (bulls,
steers and heifers). A 2-stage random sampling plan was
used to determine which pens and animals within those
pens were selected for enrolment. Animals were allocated
to the study from January 17, 2009 to September 11, 2009.
During the enrolment period, 30% of all new pens of cattle
were randomly selected for inclusion in the study using a
pen randomization table as the cattle arrived at the feedlot.
Within each selected pen, 10% of all animals in that pen
were then randomly enrolled in the study at initial proces-
sing using an individual animal randomization table. Cattle
enrolled in the study weighed a mean of 375 kg (152 to
513 kg).
All animals enrolled in the study were subject to stan-
dardized animal health management and feedlot produc-
tion procedures as per the protocols developed by the
feedlot animal health/production consultants (FHMS). In
brief, each animal received a unique individual animal
identification ear tag, a trial-specific ear tag to help identify
individuals for future sample collection, a subcutaneous
hormonal growth implant in the middle third of the ear,
vaccine(s) to immunize against selected bacteria and
viruses that cause disease in feedlot cattle, and application
of topical avermectin for internal and external parasite
control. In animals at higher risk of developing disease, a
parental antimicrobial was administered as part the pre-
vention and control strategies for bovine respiratory dis-
ease. Water and standard mixed complete feedlot diets,
formulated to meet or exceed the National Research
Council nutritional requirements for beef cattle feedlot
cattle, were offered ad libitum throughout the feeding
period.
Individual animals enrolled in the trial were sampled
twice over the course of the study: at the time of arrival
and initial processing, and then again at various times in
the middle of the feeding period when cattle were pro-
cessed again to perform standard feedlot management
procedures. Feces were collected from individual animals
per rectum using a new palpation sleeve (#33, Almedic,
Montreal, Canada) for collection and transfer (minimum 4
g) into a new sterile plastic fecal cup (# 109117, Globe
Scientific, Paramus, New Jersey). Fecal samples were
labelled, refrigerated (4°C) and transported to FHMS
within 7 days of collection. At FHMS, samples were placed
into ZipLoc bags and shipped (once a week in a chilled
cooler, by air courier (Purolator Corporation) from Cal-
gary, Alberta to the microbiology laboratory (University of
Guelph, Guelph, Ontario) for further processing.
Each fecal sample collected over the course of the trial
was assigned a unique identification number to ensure
blinding of the laboratory staff and uniform labelling of
samples. All treatments of cattle housed in the pens of cat-
tle that were enrolled and sampled for the Individual anti-
microbial use data were recorded at each feedlot over the
course of the study using a chute-side computer system
(iFHMS, FHMS). These data were available for each ani-
mal and included the product, the dose, the route and the
number of days administered. Data on both individual ani-
mal and in-feed antimicrobial exposure were collected,
with the in-feed data compiled from the pen-based feeding
records. All study data were subsequently compiled, col-
lated in a computer spreadsheet program (Microsoft
Office Excel 2003), and verified.
Clostridium difficile culture
Approximately 2 g of feces were inoculated into 9 mL of
C. difficile moxalactam norfloxacin (CDMN) enrichment
broth (Oxoid Ltd; Nepean, ON Canada) containing 0.1%
sodium taurocholate and incubated anaerobically at
37°C for 7 days. Two millilitres of broth were then
added to 2 mL of anhydrous alcohol and incubated at
room temperature for 60 min. After centrifugation
(3,980 rcf for 10 min), the pellet was inoculated onto
CDMN (Oxoid Ltd; Nepean, ON Canada) agar and
incubated in an anaerobic chamber at 37°C for 48 h
and, if negative, re-checked 3 days later. Isolation and
identification of C. difficile was based on the characteris-
tic morphology and odour of the colonies, Gram stain
and the presence of the L-proline aminopeptidase activ-
ity (Remel Inc, Lenexa, KS, USA). One single colony for
each isolate was subcultured and stored at -80°C and re-
cultured prior to molecular analysis.
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Molecular analysis
Clostridium difficile was grown on blood agar for 24 h
and approximately 10 colonies were suspended in 1 mL
of distilled water and centrifuged at 12,100 rcf for 1 min.
The supernatant was discarded and 200 μL of a commer-
cial DNA extraction kit (InstaGene Matrix; Bio-Rad,
Richmond, CA, USA) were added and incubated at 56°C
for 30 min and at 100°C for 8 min. The mixture was cen-
trifuged and 200 μL of the supernatant were frozen at
-20°C until processing.
Ribotyping was performed as described by Bidet et al.
[35]. Ribotype patterns were evaluated visually and com-
pared to an internal library of ribotypes. The interna-
tional numerical designation (e.g., ribotype 078) was used
for bacterial strains recognized as a known international
ribotype based on comparison with reference strains. A
multiplex PCR was used for detection of genes encoding
toxin A (tcdA) and toxin B (tcdB) as described by Lemee
et al. [36]. A second PCR was performed for detection of
toxin A gene constitutive difference between A-/B+
strains and A+/B+ strains, and thus, identification of
toxin A negative strains was performed according to
Kato et al. [37]. Detection of cdtA, the gene encoding for
the enzymatic component of CDT, was performed
according to Stubbs et al. [38]. Sequence analysis of the
tcdC gene was performed [39] and the result was classi-
fied according to Curry et al. [21].
Pulsed-field gel electrophoresis was performed following
the protocol used by Miller et al. [40] with modifications.
Briefly, C. difficile was cultured for 48 h and inoculated
into 3 mL of pre-reduced brain and heart infusion (BHI)
solution and grown anaerobically for 6 h. The solution
was then adjusted to have an optical density (OD)600
between 0.3 and 0.7. Four hundred microlitres of the solu-
tion were centrifuged at 12,000 rcf for 1 min and the pellet
suspended in 150 μL of cell lysis buffer and added 150 μL
of melted 1% SeaKem Gold PFGE agarose (Cambrex
BioScience Rockland Inc., ME, USA) plus 1% SDS for
pipetting into plug molds. After solidified, plugs were
transferred into 500 μL of lysis buffer added by 25 μL of
lysozyme (final concentration 20 mg/mL) and 25 μL of
mutanolysin (final concentration 12.5 U/mL) and incu-
bated at 37°C overnight. The solution was then replaced
by 500 μL of proteinase K (PK) buffer added by 25 μL of
PK (final concentration 20 mg/mL) and incubated over-
night at 56°C for 4 h. Plugs were rinsed three times with 1
× TE buffer and placed on a shaker for 5 min. The last
step was repeated once and three more washes were per-
formed with intervals of 10, 15 and 20 min. The solution
was replaced by 150 μL of buffer A (New England Biolabs,
ON, Canada) and after 10 min replaced by buffer A plus
60 U of restriction enzyme SmaI and incubated at 25°C
overnight. Half of the plug was cut off and transferred to
wells of a 1.3% pulsed-field certified agarose gel (BioRad,
CA, USA). DNA separation was performed in a CHEF-DR
II chamber (BioRad, CA, USA) added of 2.2 L of 0.5× TBE
buffer plus 500 μL of 0.2 M thiourea, set to run for 22 h at
6 V/cm with initial switch time of 1 sec and final switch
time of 40 sec. The gel was stained in ethidium bromide
and images were obtained using a computerized system
(SynGene, Synoptics, MD, USA).
Antimicrobial use data
Individual animal exposure data regarding antimicrobial
drugs were recorded at each feedlot over the course of the
study using a chute-side computer system (iFHMS, Oko-
toks, Alberta). These data included the product used, the
dose, and the date and route of administration. All study
data were subsequently compiled, collated in a computer
spreadsheet and verified. Ionophores, and coccidiostats
were not included in this analysis.
Dosage information for exposures to antimicrobial drugs
was converted into an Animal Defined Daily Dose (ADD).
The ADD metric represents the number of days of treat-
ment for an animal based on an assumed average mainte-
nance dosage needed for clinical therapy. Dosage
conversion to ADD was based on the expected length of
drug effect as indicated by approved dosages.
Statistical analysis
The least square means estimates and 95% confidence
intervals for the prevalence of C. difficile at arrival and the
second (post-arrival) time point were modelled using
logistic regression. Regression analysis using generalized
estimating equation (GEE) methods, was used to correct
prevalence estimates for lack of independence related to
sampling of multiple individuals from the same pens using
a compound symmetry (exchangeable) correlation struc-
ture. Logistic regression was performed using commer-
cially available software (SAS version 9.2, SAS Institute
Inc, Cary, NC).
Date of sampling during the feeding period (< 62 days
on feed (DOF), 62-71 DOF, or > 71DOF) and exposure of
cattle to antimicrobial drugs. Antimicrobial exposure data
were summarized as ADDs administered parenterally or
in feed between arrival and second sampling, by class of
antimicrobial drug, and by route of administration (beta
lactams, macrolides, phenicols, quinolones, tetracyclines,
and sulfonamides for parenteral exposures and tetracy-
clines for in-feed exposures).
The outcome for the logistic models was the presence or
absence of C. difficile. Variables were screened in univari-
able models to determine those to be included in multi-
variable model building using a critical alpha for inclusion
of 0.25. Multivariable models were not assessed since
none of the antimicrobial exposure variables met the
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inclusion criteria. Odds ratios, 95% confidence intervals
(95%CI), and the associated P-values were reported from
logistic regression models.
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